Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Patterns and Clinical Outcomes Among Indian Patients Receiving Palbociclib Combinations for HR+/HER2- Advanced/Metastatic Breast Cancer in Real World Settings

NCT05584644 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05584644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05584644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Patterns and Clinical Outcomes Among Indian Patients Receiving Palbociclib Combinations for HR+/HER2- Advanced/Metastatic Breast Cancer in Real World Settings
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
May 24, 2021
Completion date
February 22, 2022
Enrollment
150 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast carcinoma, breast neoplasms, breast tumors, cancer of breast